The Two Faces of Fish Oil

The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Written byCatherine Offord
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© ISTOCK.COM/CHUYN

Emile Voest, a professor of medical oncology and medical director of The Netherlands Cancer Institute, has spent his career studying the tumor microenvironment—cancer’s cellular backdrop, implicated in everything from a tumor’s structural support to its protection from the immune system and its resistance to cancer-treating drugs.

But it came as some surprise, Voest says, when, in the mid-2000s, he and his colleagues identified two obscure polyunsaturated fatty acids—16:4(n-3) and KHT—that seemed to induce chemoresistance in tumor-bearing mice. “It was not what I was expecting at all,” says Voest. “We had no clue what fatty acids were [or] how they worked.”

The researchers found that human mesenchymal stem cells (multipotent stromal cells already implicated in drug resistance) injected into tumor-bearing mice began secreting these fatty acids ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies